Lens-Induced Glaucoma

Etiology

Lens-induced glaucoma develops when progressive cataract changes alter the anatomical and biochemical environment of the anterior segment, thereby obstructing aqueous outflow or causing pupillary block. Prolonged cataract maturation increases capsular permeability, the risk of protein leakage, zonular instability, and phacolytic or phacomorphic mechanisms.[10] The underlying etiology varies by subtype, but all mechanisms share a common pathway: increased IOP resulting from impaired aqueous humor drainage (see Table 1).[2]

The first 3 forms of lens-induced glaucoma are related to lens protein leakage:

• Phacolytic ecmhanism (hypermature cataract leakage)
  • In hypermature or Morgagnian cataracts, the lens capsule becomes fragile. High-molecular-weight lens proteins leak into the anterior chamber, triggering macrophage recruitment. Swollen macrophages then obstruct the trabecular meshwork, reducing aqueous outflow and sharply elevating IOP. The chamber depth remains regular or deep (see Image. Phacolytic Glaucoma).[11]
• Lens particle–induced mechanism (retained lens matter)
  • Following cataract surgery, trauma, or spontaneous capsular rupture, cortical or nuclear lens fragments may enter the anterior chamber. These particles directly obstruct trabecular outflow and induce secondary inflammatory trabeculitis, thereby elevating IOP (see Image. Lens Particle Glaucoma).[12]
• Phacoanaphylactic (lens-induced uveitic) mechanism
  • This subtype is an immune-mediated granulomatous reaction to exposed lens proteins after surgery or trauma, resulting in intense anterior uveitis. Fibrin and inflammatory cells, particularly macrophages, clog the trabecular meshwork, dramatically reducing aqueous outflow (see Image. Phacoanaphylactic Glaucoma).[13]

The additional 2 forms of lens-induced glaucoma relate to mechanical obstruction of aqueous flow:

• Phacomorphic mechanism (intumescent lens)
  • As a cataract matures, osmotic changes cause the lens to swell. The increased lens volume pushes the iris anteriorly, narrows the anterior chamber angle, and produces a relative pupillary block. This culminates in acute angle-closure glaucoma, often associated with severe pain, corneal edema, and markedly elevated IOP (see Image. Phacomorphic Glaucoma).[8]
• Pupillary block mechanism (lens subluxation/dislocation) (includes the mechanism previously known as phacotopic)
  • Zonular dialysis caused by trauma, pseudoexfoliation, or systemic connective-tissue disorders (eg, Marfan, homocystinuria) results in a displaced lens. The dislocated or subluxated lens may:
    • Block the pupil
    • Tilt forward, causing the angle to narrow
    • Mechanically obstruct the trabecular meshwork [2]

Table 1. Etiologic Classification of Lens-Induced Glaucoma

Congenital ectopia lentis can lead to obstruction of aqueous outflow, predisposing affected individuals to lens-induced glaucoma. Various forms include the following:

• Marfan syndrome: Bilateral supero-temporal subluxation of the lens with occasional acute dislocation and primary bilateral glaucoma (PBG) in early childhood [14]
• Homocystinuria: Bilateral inferonasal lenticular subluxation with acute anterior chamber dislocation and PBG [15]
• Weill-Marchesani syndrome: Associated with microspherophakia, ciliary body hypoplasia, PBG, and inverse glaucoma
• Others: Ehler-Danlos syndrome, sulfite oxidase deficiency, hyperlysinemia, aniridia, Alport syndrome, Axenfeld-Rieger syndrome, and Peter anomaly type 3

Acquired causes of lens-induced glaucoma include the following:

• Trauma: Traumatic injury can directly cause anterior lens dislocation and PBG, and lens capsule rupture can cause immediate lens particle–induced glaucoma (LPIG) or delayed phacomorphic angle-closure glaucoma (PAG).
• Post cataract surgery: Retained loose lenticular matter can precipitate an acute attack of LPIG or a chronic PAG.
• Iatrogenic (intraocular procedures): Accidental rupture of the lens capsule can occur during anterior chamber procedures (eg, laser-assisted iridotomy, intracameral injections, trabeculectomy, minimally invasive glaucoma surgeries), posterior lamellar corneal surgeries, or posterior segment procedures (eg, intravitreal injections, pars plana vitrectomy), leading to immediate LPIG or a delayed PAG.
• Intumescent cataract: The enlarged lens may cause phacomorphic glaucoma (PMG), particularly in settings of delayed surgical intervention or limited access to cataract care.
• Hypermature senile cataract: Micro-ruptures in the lens capsule allow leakage of lens proteins, resulting in PLG.[3]
• Zonular weakness or capsular fragility: Systemic conditions affecting the zonules, pseudoexfoliation (PXF) syndrome, and chronic uveitis may predispose to lens subluxation, dislocation, or capsular compromise, increasing the risk of pupillary block glaucoma or lens protein–related glaucoma (see Table 2).[16]

Table 2. Risk Factors for Lens-Induced Glaucoma

Epidemiology

Lens-induced glaucoma remains a significant cause of secondary glaucoma globally, although its epidemiology varies significantly between high-, low-, and middle-income countries. The condition is strongly associated with untreated cataract progression, delayed access to surgical care, and demographic factors such as age, socioeconomic status, and geographic location. As a result, its frequency is highest in regions where uptake of cataract surgery is low or significantly delayed.[3] In low-resource countries with more limited access, acquired lens-induced glaucoma from advanced age-related cataracts is the more prevalent subtype. The incidence of lens-induced glaucoma is up to 2.4% at the time of the presentation of age-related cataracts, with a greater preponderance in women.[1] In contrast, the estimated prevalence of congenital ectopia lentis is 6.4 per 100,000 population.[17]

Globally, lens-induced glaucoma accounts for 3% to 10% of all secondary glaucomas, with the highest burden observed in South Asia, Southeast Asia, and sub-Saharan Africa. In rural Indian studies, lens-induced glaucoma may represent 9% to 14% of all acute glaucoma admissions, particularly in underserved populations. Numerous screening programs in India and Nepal have identified hypermature and intumescent cataracts as major precursors of lens-induced glaucoma, reflecting the persistence of late-stage cataracts in these regions. Worldwide, the condition remains tightly linked to the prevalence of age-related hypermature cataracts, which disproportionately affect populations with limited access to surgical ophthalmic care.[2]

In contrast, the incidence of lens-induced glaucoma in high-income countries such as the United States (US), Canada, Japan, and Western Europe is markedly lower. Improved access to cataract surgery, insurance coverage, routine ophthalmic evaluations, and public awareness initiatives have significantly reduced progression to hypermaturity. In the US, lens-induced glaucoma accounts for less than 1% of all glaucoma cases, and acute presentations are rare. However, specific variants (most notably lens particle glaucoma following cataract surgery or trauma) may still occur even in advanced healthcare settings. These cases often result from retained cortical material or delayed postoperative follow-up rather than cataract neglect.[8]

Sex distribution of lens-induced glaucoma varies by region and reflects broader disparities in access to cataract care rather than biological predisposition. Globally, women are disproportionately affected, especially in rural Asia and Africa. In many low-resource settings, women have significantly less access to cataract surgery due to socioeconomic factors, cultural roles, or mobility limitations. As a result, hypermature cataracts and subsequent lens-induced glaucomas occur more frequently in older women, with female-to-male ratios reported between 1.3:1 and 1.8:1 in several community-based studies. However, in regions with equitable healthcare access, such as the US and Western Europe, lens-induced glaucoma does not show a meaningful sex-based predilection.[4]

The epidemiology of lens subluxation–related glaucomas (PBG, or "phacotopic") shows a different pattern (see Table 3). This subset is more common in regions with high prevalence of trauma, pseudoexfoliation syndrome, and hereditary connective tissue disorders. In areas such as Nepal, northern India, and Kurdish regions where PXF is endemic, lens subluxation contributes meaningfully to lens-induced glaucoma burden.

Age remains the strongest epidemiologic determinant (see Table 4). Lens-induced glaucoma primarily affects older individuals with long-standing age-related cataracts. The typical age at presentation in low- and middle-income countries ranges from 60 to 80 years, although cases in the 50 to 60-year age group are increasing in some regions due to earlier cataract onset associated with diabetes, ultraviolet exposure, steroid use, and nutritional deficiencies. In high-income countries, lens particle glaucoma can present at any adult age following cataract surgery, trauma, or complicated procedures. In contrast, phacomorphic and phacolytic variants are typically restricted to individuals in the oldest age strata who have avoided or deferred surgery.[7]

Globally, population aging is expected to increase the number of individuals with cataracts, particularly in Asia and Africa, thereby sustaining the risk of lens-induced glaucoma. According to projections from the World Health Organization, the burden of cataract blindness in low-resource settings is increasing among older adults, who are living longer but may still lack timely access to cataract care. Consequently, although cataract surgery volumes have increased worldwide, the absolute number of people at risk for lens-induced glaucoma remains high in underserved regions.[5]

Rural–urban differences also strongly influence epidemiology. Rural communities, particularly in low-income countries, exhibit significantly higher rates of hypermature cataracts and lens-induced glaucoma due to limited hospital access, long travel distances, a shortage of ophthalmologists, and cultural preferences for home-based or traditional treatments. Studies from India, Nepal, Pakistan, and Ethiopia consistently show a 2 to 4 times higher risk of lens-induced glaucoma in rural versus urban populations.[18]

Socioeconomic status further modifies epidemiologic patterns. Individuals from lower-income groups are more likely to delay cataract surgery due to financial constraints, fear of surgery, or lack of awareness. Community-based surveys have shown that patients presenting with lens-induced glaucoma often have no prior ophthalmic consultation, reinforcing the role of access barriers in disease progression.

Ethnic variation in lens-induced glaucoma prevalence largely parallels global cataract epidemiology. Populations with higher cataract burdens (eg, South Asian and East African) exhibit higher frequencies of lens-induced glaucoma. In the US, racial disparity is less pronounced, although Black and Latino populations exhibit higher rates of postoperative retained lens matter and trauma-related lens complications, potentially influencing the epidemiology of lens particle glaucoma.[19]

Overall, while lens-induced glaucoma is rare in the US and other high-income nations, it remains a significant public health concern in low- and middle-income countries, particularly among older women in rural communities. The frequency of this condition is closely linked to cataract maturity, access to surgical services, population awareness, and age distribution. As global aging and diabetes prevalence rise, the natural incidence of cataract is expected to increase further, underscoring the need for continued public health strategies aimed at timely cataract detection and surgery to prevent the avoidable morbidity of lens-induced glaucoma.[20]

Table 3. Global Epidemiology of Lens-Induced Glaucoma 

Table 4. Sex- and Age-Based Distribution of Lens-Induced Glaucoma 

Pathophysiology

Lens-induced glaucoma encompasses a group of secondary glaucomas caused by structural and biochemical alterations of the crystalline lens that disrupt aqueous humor dynamics. Although each lens-induced glaucoma subtype has distinct initiating events, the final common pathway is obstruction of aqueous outflow due to mechanical crowding, trabecular meshwork (TM) blockage, or inflammatory trabeculitis, resulting in elevated IOP. The pathophysiology reflects a complex interaction between lens enlargement, capsular integrity, protein leakage, macrophage activation, zonular disruption, and anterior segment anatomy.[21] The first 3 forms of lens-induced glaucoma are related to lens protein leakage.

Phacolytic Glaucoma (Protein Leakage and Macrophage Blockade)

Phacolytic glaucoma (PLG) occurs in eyes with hypermature or Morgagnian cataracts, in which the lens cortex liquefies due to long-standing degeneration, leading to microscopic defects in the lens capsule that allow high-molecular-weight α-crystallin proteins to progressively leak into the anterior chamber. Flocks coined the term "phacolytic glaucoma", and Epstein described the role of high-molecular-weight lens protein (HMW-LP) in the pathogenesis of PLG.[22][23] These leaked proteins trigger an inflammatory response resulting in:

• Recruitment of macrophages
• Phagocytosis of leaked lens proteins
• Engorgement and impaired mobility of the macrophages
• Accumulation of macrophages and protein aggregates in the trabecular meshwork

The TM becomes clogged, producing severe outflow resistance and acute open-angle glaucoma. Unlike phacomorphic glaucoma, phacolytic glaucoma is characterized by a deep anterior chamber and open angles. Pupillary block is absent; the obstruction is purely at the TM level.[24][23] Clinically, phacolytic glaucoma presents with a red, painful eye and a floating white material (“milky fluid”) in the anterior chamber.

Key mechanisms:

• Lens protein leakage
• Macrophage activation
• TM blockage by protein-laden macrophages
• High IOP due to outflow failure

Notably, a recent theory posits that high-molecular-weight lipopolysaccharides (HMW-LPs) directly obstruct the TM, thereby impeding aqueous outflow and precipitating PLG. The increase in HMW-LP content in the human lens with age supports this theory.

Lens Particle–Induced Glaucoma (Mechanical Obstruction by Cortex/Nucleus)

LPIG occurs when cortical or nuclear fragments enter the anterior chamber after the lens capsule is breached, following:

• Cataract surgery (retained lens matter)
• Trauma
• Spontaneous capsule rupture in hypermature cataracts

In this subtype, lens particles directly obstruct the TM and induce secondary inflammatory trabeculitis, further reducing aqueous flow. The immune response leads to the accumulation of inflammatory cells, fibrin, and debris within the TM. IOP elevation may be acute or subacute, depending on particle load and inflammatory intensity.[4] 

Key mechanisms:

• Direct TM obstruction by lens fragments
• Trabeculitis-induced edema of TM
• Secondary inflammation → increased outflow resistance

Because the inflammation in LPIG is secondary to lens capsule breach and subsequent mechanical obstruction by the released particulate lens material, the resulting uveitis is generally more pronounced than in phacolytic glaucoma.[7]

Phacoanaphylactic Glaucoma (Immune-Mediated Granulomatous Reaction)

PAG, sometimes referred to as lens-induced uveitic or phacoantigenic glaucoma, is a rare subtype that results from a type III hypersensitivity reaction to lens proteins after lens capsule rupture. The release of lens particles is similar to LPIG; however, in PAG, the immune system specifically recognizes previously sequestered lens proteins as foreign, triggering a granulomatous inflammatory response. The inflammation of the TM is mediated by an Arthus reaction (a subtype of type III hypersensitivity) involving immunoglobulin G and the complement system.[25] Verhoeff and Lemoine described this entity as endophthalmitis phacoanaphylactica.[26] This is the most immunologically active form of lens-induced glaucoma.

Histopathology shows:

• Giant cell reaction
• Macrophages and lymphocytes
• Zonular and capsular remnants surrounded by inflammatory cells
• Trabecular meshwork infiltration with inflammatory cells

Inflammatory trabeculitis reduces aqueous outflow and sharply increases IOP. There is a sensitization period of 1 to 14 days between the release of the glaucoma-causing agent and the onset of glaucoma.[27] Because the reaction may start days to weeks after surgery or trauma, the presentation may be delayed.

Key mechanisms:

• Autoimmune sensitization to lens proteins
• Granulomatous inflammation
• TM infiltration with immune cells
• Severe outflow obstruction

The additional 2 forms of lens-induced glaucoma are attributable to mechanical obstruction of aqueous outflow.

Phacomorphic Glaucoma (Mechanical Pupillary Block)

PMG develops when an intumescent swollen lens increases in anteroposterior diameter due to the osmotic hydration associated with advanced cataract maturation. As the lens enlarges, it pushes the iris diaphragm forward, resulting in:

• Shallowing of the anterior chamber
• Crowding of the iridocorneal angle
• Iris–lens apposition at the pupillary border

This process produces relative pupillary block, reducing aqueous movement from the posterior to the anterior chamber. Fluid accumulates behind the iris, causing iris bombe, which further narrows or closes the angle. Without intervention, the aqueous outflow decreases dramatically, leading to a rapid rise in IOP. Persistent angle closure may lead to peripheral anterior synechiae (PAS), rendering the condition irreversible over time.

Key mechanisms:

• Increased lens thickness
• Forward displacement of the iris
• Pupillary block → iris bombe
• Angle closure → trabecular outflow obstruction

This mechanism explains the classic presentation of acute, painful, angle-closure glaucoma with corneal edema in the setting of a sudden increase in the volume of a cataractous lens.[28] Clinically, acute angle-closure with a shallow anterior chamber and an open angle in the contralateral eye suggests PMG.[29] 

Pupillary Block Glaucoma Due to Lens Displacement (Previously Termed Phacotopic Glaucoma)

In pupillary block glaucoma (historically termed phacotopic glaucoma), zonular weakness due to trauma, PXF, or systemic connective tissue disorders (eg, Marfan syndrome, homocystinuria, Weill-Marchesani syndrome) leads to displacement of the crystalline lens (ectopia lentis) and subsequent blockage of aqueous flow.[30] The lens may:

• Move forward
  • Forward subluxation pushes the iris anteriorly, causing:
    • Shallow anterior chamber
    • Pupillary block
    • Acute angle closure [7]
• Dislocate into the anterior chamber
  • Direct obstruction of the pupil or TM by the lens
• Dislocate into the vitreous
  • May cause reverse pupillary block or intermittent IOP spikes

Key mechanisms:

• Mechanical obstruction of the pupil
• Angle narrowing
• TM compression by a dislocated lens

This subtype is intensely mechanical and often presents acutely. Although phacomorphic and pupillary block (phacotopic) glaucomas arise from different initiating events (lens enlargement versus lens displacement), both ultimately produce pupillary block and secondary angle closure through mechanical obstruction of aqueous flow.

Final Common Pathway: Aqueous Outflow Failure → Elevated IOP

Regardless of the initiating mechanism, lens-induced glaucoma results in one of two final pathways:

Trabecular meshwork obstruction

Seen in:

• Phacolytic glaucoma
• Lens particle glaucoma
• Phacoanaphylactic glaucoma

Pupillary block → angle closure

Seen in:

• Phacomorphic glaucoma
• Anterior lens dislocation (eg, pupillary block glaucoma due to congenital ectopia lentis)

In both pathways, the result is a dramatic rise in IOP, which in some cases exceeds 40 to 60 mm Hg.

Sustained elevated IOP leads to:

• Optic nerve head ischemia
• Retinal ganglion cell apoptosis
• Irreversible glaucomatous optic neuropathy
• Acute loss of visual acuity

Additionally, corneal endothelial dysfunction due to elevated IOP causes corneal edema, further impairing visualization and delaying diagnosis.[4]

Anatomical Predispositions Compounding Pathophysiology

Certain anatomical factors increase susceptibility:

• Pre-existing shallow anterior chamber
• Hyperopic eyes (short axial length)
• Pseudoexfoliative zonulopathy
• Small corneal diameter
• Narrow drainage angles [31]

These factors reduce compensation when the lens enlarges or dislocates, causing earlier and more severe IOP spikes. (see Table 5).

Table 5. Comprehensive Comparison of All Subtypes of Lens-Induced Glaucoma

AC, anterior chamber; CTD, connective tissue disease; IOP, intraocular pressure; PXF, pseudoexfoliation; PAS, peripheral anterior synechiae; TM, trabecular meshwork

Histopathology

Lens-induced glaucoma encompasses several pathophysiological mechanisms, each with a characteristic histopathologic signature. Although all subtypes ultimately lead to elevated IOP and glaucomatous optic nerve damage, microscopic evaluation reveals distinct patterns involving the lens capsule, lens proteins, inflammatory cells, and the TM. These changes help differentiate between phacolytic, lens particle, phacoanaphylactic, phacomorphic, and pupillary block (phacotopic) glaucomas.[3]

Histopathology of Phacolytic Glaucoma

The hallmark of phacolytic glaucoma is protein leakage from a hypermature cataract through microscopic capsular defects.

Key microscopic features

• Lens
• Hypermature lens with liquefied cortex (“Morgagnian degeneration”)
• Thin, wrinkled capsule with microfissures
• Anterior chamber
• Abundant high-molecular-weight lens proteins
• Numerous macrophages containing ingested crystallin proteins, often swollen and vacuolated
• Trabecular meshwork
• Obstruction by macrophages, large protein globules, and fine granular material
• Reduced porosity of trabecular spaces
• Mild secondary trabeculitis
• Iris
• Mild inflammatory cell infiltration
• Cornea
• Endothelial cell stress and edema [32]

Phacolytic glaucoma is characterized by protein–macrophage trabecular obstruction, which explains the elevated IOP despite a deep anterior chamber.

Histopathology of Lens Particle Glaucoma

Lens particle glaucoma follows cataract surgery or trauma and involves retained cortical/nuclear fragments.

Key microscopic features

• Lens
• Extruded cortical material within the anterior chamber
• Pink, eosinophilic lens fragments, often with degenerating nuclei
• Inflammatory cells
• Prominent macrophages and neutrophils surrounding lens fragments
• Macrophages containing cortical debris (“phagocytic clusters”)
• Trabecular meshwork
• Mechanical obstruction by lens particles, inflammatory cells, and cellular debris
• Reactive trabeculitis with edema of TM beams
• Iris and ciliary body
• Moderate uveitis with vascular congestion
• Cornea
• Stromal edema from elevated IOP [33]

Lens particle glaucoma is a combination of mechanical obstruction + inflammatory TM dysfunction.

Histopathology of Phacoanaphylactic Glaucoma

This immune-mediated subtype involves a granulomatous hypersensitivity reaction to liberated lens proteins.

Key microscopic features

• Anterior chamber
• Dense granulomatous inflammation
• Giant cells, polymorphonuclear (PMNs) leukocytes, epithelioid histiocytes, and lymphocytes
• Fibrinous exudate
• Lens material
• Residual fibers surrounded by granulomas
• Microscopic capsular breaks
• Trabecular meshwork
• Packed with inflammatory cells and fibrin
• Granulomatous infiltration in TM beams
• Iris and ciliary body
• Severe granulomatous iridocyclitis
• Possible synechiae from chronic inflammation
• Cornea
• Keratic precipitates ("mutton-fat") on the endothelium [32]

This subtype is the most histologically intense, displaying classic autoimmune granulomas directed against lens antigens. Unlike phacolytic glaucoma, which shows a chronic inflammatory reaction with macrophages engulfing lens proteins, phacoanaphylactic glaucoma has a granulomatous reaction zone with giant cells, PMNs, epithelioid cells, and a cuff of lymphocytes and plasma cells.[34][35]

Histopathology of Phacomorphic Glaucoma

Phacomorphic glaucoma arises primarily from mechanical angle closure secondary to a swollen lens, and histopathological changes reflect structural crowding rather than biochemical inflammation.

Key microscopic features

• Lens
• Enlarged, intumescent cortex with liquefaction of superficial fibers
• Intact lens capsule
• Iris
• Anterior bowing due to pupillary block
• Possible focal ischemia from prolonged contact with the lens
• Trabecular meshwork
• Appositional closure with minimal inflammatory cell infiltration
• Secondary formation of peripheral anterior synechiae in chronic cases
• Anterior chamber angle
• Narrow or closed, but devoid of proteinaceous debris
• Cornea
• Endothelial edema due to an acute IOP rise
• Descemet folds [8]

Phacomorphic glaucoma is mechanical and non-inflammatory, and histology primarily reflects changes in iris–lens configuration and anterior chamber angle anatomy, rather than TM obstruction by cells or proteins.

Histopathology of Pupillary Block Glaucoma (Subluxation/Dislocation)

In pupillary block glaucoma (historically termed phacotopic glaucoma), lens displacement causes mechanical obstruction and may damage the trabecular meshwork (see Table 6).

Key microscopic features

• Zonules
• Zonular weakening or rupture
• Pseudoexfoliative deposits (if PXF is present)
• Lens
• Anterior displacement (with angle/pupillary block) or posterior displacement
• Typically intact lens capsule, unless disrupted by trauma
• Trabecular meshwork
• Pigment dispersion, particularly in traumatic lens dislocation
• Possible focal indentation or compression if the lens contacts the angle
• Local collapse or mechanical distortion
• Iris
• Irregular pupil, stretched iris root
• Angle recession in traumatic cases
• Cornea
• Possible endothelial cell loss due to lens–endothelium contact [36]

This subtype is characterized by zonular pathology and mechanical angle changes, not by protein leakage or an immune reaction.

Common Final Histopathologic Pathway (All Forms)

Regardless of subtype, the consequences of untreated lens-induced glaucoma include:

• TM damage and collapse
• Optic nerve head cupping (loss of ganglion cells, lamina cribrosa thinning)
• Retinal nerve fiber layer loss
• Corneal endothelial decompensation

These complications are the result of chronic IOP elevation leading to irreversible glaucomatous optic neuropathy.[37]

Table 6. Histopathologic Fingerprints of Lens-Induced Glaucoma Subtypes

Toxicokinetics

Lens-induced glaucoma is not caused by external toxic substances; rather, the pathogenesis of lens protein–related subtypes closely parallels the principles of ocular toxicokinetics, in which lens-derived proteins, inflammatory mediators, macrophages, and particulate debris function as endogenous “toxins” within the confined ocular environment. Toxicokinetics in lens-induced glaucoma describes how these biologically active materials are released and distributed, how they accumulate and interact with ocular tissues, and how they are ultimately cleared, and how their kinetic behavior contributes to trabecular outflow failure and IOP elevation.

Source of the Endogenous “Toxic Load”

Different subtypes of lens-induced glaucoma introduce unique substances into the aqueous humor.

High-molecular-weight lens proteins (phacolytic glaucoma)

• Derived from a hypermature, liquified cortex
• Include crystallins, degraded peptides, and osmotic proteins
• Leak through microscopic capsular defects
• Overwhelm normal aqueous clearance capacity [3]

Lens cortex/nuclear fragments (lens particle glaucoma)

• Released after capsular rupture due to trauma or surgery
• Act as solid particulate toxins obstructing TM pores [2]

Immunogenic lens proteins (phacoanaphylactic glaucoma)

• Delayed autoimmune granulomatous inflammation triggered by exposed crystallins
• TM damage caused by inflammatory cytokines behaving as biochemical toxins [8]

Mechanical lens mass (phacomorphic and pupillary block [phacotopic] glaucomas)

• Aqueous kinetics altered by mechanical compression, not biochemical release

Absorption and Entry Into Ocular Tissues

The anterior chamber acts as a closed kinetic compartment.

Phacolytic lens proteins

• Enter the aqueous via capsular micro-channels
• Rapidly diffuse through aqueous but poorly traverse the TM due to size
• Protein concentration increases because production > clearance [5]

Lens particles

• Direct retention within the angle
• Become coated with inflammatory cells → greater obstruction

Immunogenic proteins

• Trigger the recruitment of macrophages, T cells, and giant cells
• Widespread diffusion of cytokines (interleukin-1, tumor necrosis factor-alpha, interferon-gamma) in the anterior chamber

Distribution and Accumulation (Key Toxicokinetic Step)

Because the eye has minimal fluid turnover, any foreign proteins or debris accumulate rapidly.[9]

Accumulation in the trabecular meshwork

• TM is the primary site of toxic deposition.
• Macrophage–protein aggregates physically block TM pores.
• Cytokines induce TM edema, reducing outflow facility.
• Particles become lodged in juxtacanalicular tissue.

Accumulation in the anterior chamber

• Protein concentration increases, resulting in a Tyndall (aqueous) flare.
• Lens particles remain suspended until phagocytosed.[38]

Macrophage dynamics

• Macrophages ingest lens proteins and rapidly become ballooned, immobile cells.
• These swollen macrophages cannot exit via the TM, worsening obstruction.

Metabolism, Breakdown, and Biochemical Reactions

The breakdown of lens-derived materials follows unique ocular kinetics.

Lens proteins

• Poorly degraded in aqueous humor due to a lack of proteolytic enzymes
• Persist for long durations, prolonging toxic exposure
• Degraded fragments remain highly osmotic → draw more fluid → inflammatory amplification [39]

Lens particles

• Undergo slow enzymatic degradation by macrophages
• Incomplete breakdown leads to chronic TM loading

Immunogenic proteins

• Trigger granulomatous reactions → cytokines → further TM dysfunction
• Long-term alterations to TM permeability due to persistent inflammation

Clearance and Elimination

Clearance is dramatically impaired in lens-induced glaucoma.

Normal aqueous outflow clearance

• Via TM → Schlemm canal → episcleral veins
• Efficient only for small soluble proteins [3]

Clearance failure in lens-induced glaucoma

• High-molecular-weight proteins cannot pass TM spaces.
• Debris-laden macrophages physically block outflow.
• Granulomatous inflammation reduces trabecular porosity.
• Mechanical angle closure prevents access to outflow pathways.

Thus, the rate of accumulation exceeds the rate of clearance, resulting in an escalating IOP.

Toxicodynamic Effects: How the “Toxic Load” Causes Damage

These biological materials exert toxicodynamic effects on the following ocular tissues (see Table 7).[40]

Trabecular meshwork

• Mechanical obstruction
• Edema from cytokines
• Macrophage infiltration
• Collapse of TM beams
• Reduced outflow capacity

Iris and ciliary body

• Inflammatory hyperemia
• Uveitic infiltrates
• Synechiae formation

Corneal endothelium

• Protein-laden aqueous and high IOP cause endothelial dysfunction.
• Endothelial cell loss leads to persistent corneal edema.

Optic nerve

• Sustained high IOP → ischemia → axonal apoptosis
• Rapid increase in cup–disc ratio in acute lens-induced glaucoma[41]

Table 7. Summary of Toxicokinetic Principles in Lens-Induced Glaucoma

Clinical Implications of Toxicokinetics in Lens-Induced Glaucoma

• Earlier surgical removal stops protein leakage (“source control”).
• Anti-inflammatory therapy modulates cytokine-mediated toxicodynamics.
• Rapid IOP control protects the corneal endothelium from toxic exposure.
• Delayed clearance leads to chronic TM damage and irreversible vision loss.

History and Physical

In evaluating a patient with suspected lens-induced glaucoma, a detailed history of the onset, duration, and progression of the presenting symptoms is essential. The clinician must note any history of similar episodes or ocular surgery. A clinical history suggestive of a contraindication to systemic steroid use, like osteoporosis, peptic ulcer disease, psychiatric illness, or tuberculosis, should also be elicited. Lens-induced glaucoma typically presents in older individuals with long-standing, untreated cataracts. Presentations vary widely depending on the underlying subtype—phacolytic, lens particle, phacoanaphylactic, phacomorphic, or pupillary block (phacotopic) glaucoma. A careful, detailed history, combined with targeted examination, strongly suggests the diagnosis before imaging or gonioscopy (see Table 8).[3]

History

Presenting concerns

Patients commonly report:

• Sudden or subacute onset of severe unilateral eye pain
• Redness of the eye
• Rapid decline in vision
• Halos around lights
• Headache (often severe, frontal or hemicranial)
• Nausea and vomiting (due to acute IOP rise)
• Photophobia and tearing

Some forms (phacolytic, lens particle glaucoma) may present more subacutely with gradual visual decline and mild pain.[2]

Symptom timeline

• Phacolytic glaucoma: Subacute onset over days to weeks due to hypermature cataract leakage
• Lens particle glaucoma: Symptom onset either postoperative (after cataract surgery) or after ocular trauma; typically within hours to days
• Phacoanaphylactic glaucoma: Develops 1 to 14 days after lens capsule rupture or cataract surgery
• Phacomorphic glaucoma: Acute onset over hours to days; often follows periods of glare or sudden pupillary dilation (dim light, stress, sleep)
• Pupillary block (phacotopic) glaucoma: Intermittent episodes of blurred vision or pain due to shifting lens position (subluxation/dislocation)[42]

Relevant past history

• Ocular history
  • Long-standing poor vision from cataract
  • History of trauma
  • Previous intraocular surgery (phacoemulsification, extracapsular, or intracapsular cataract extraction)
  • Retained lens fragments after surgery
  • Recurrent episodes of blurry vision or monocular diplopia (lens subluxation)
  • Previous episodes of angle closure [21]
• Systemic history
  • Diabetes mellitus
  • Connective tissue disorders (Marfan, homocystinuria, Weill-Marchesani syndrome)
  • PXF
  • Steroid use (earlier cataract maturation) [43]
• Delayed access to care
  • Fear of surgery
  • Socioeconomic constraints
  • Rural residence or lack of ophthalmic services [3]

Table 8. Specific History by Subtype

Physical Examination

General inspection

• Signs of patient distress, including nausea or photophobia
• Marked conjunctival congestion and chemosis, especially ciliary flush
• Dilated episcleral vessels
• Eyelid erythema or edema [2]
• Facial asymmetry or abnormal head posture, suggesting associated neurologic or ocular motility abnormalities
• Abnormal binocular alignment, including sensory exotropia in eyes with advanced cataract and poor vision
  • Longstanding comitant strabismus since childhood suggests poor visual prognosis in unilateral ectopia lentis (EL) cases

Visual acuity

• Best-corrected visual acuity measured with Snellen or LogMAR chart, with attention to any improvement with the pinhole
• Typically markedly reduced due to cataract and corneal edema
• Ranging from counting fingers to hand motion, depending on corneal clarity and cataract severity
• Cycloplegic refraction performed for EL

Slit-lamp examination

• Cornea
  • Stromal edema, subepithelial bullae, and Descemet membrane folds (due to high IOP)
  • Microcystic epithelial edema [44]
  • Fresh keratitic precipitates (KPs) on the posterior surface of the cornea in PLG and PAG
  • Lens proteins are deposited on the posterior surface in LPIG
• Anterior chamber 
  • Phacolytic
    • Deep anterior chamber (AC)
    • Floating white lens proteins with flare, mobile macrophages, and hyper-refringent crystalline particles (eg, calcium oxalate or cholesterol crystals) [45]
    • Occasional pseudohypopyon [46]
  • Lens particle
    • Visible lens fragments in AC
    • Cells, flare, fibrin
  • Phacoanaphylactic
    • Severe granulomatous uveitis
    • "Mutton-fat" keratic precipitates
    • Prominent flare, often intense with fibrin
  • Phacomorphic
    • Very shallow AC centrally and peripherally
    • Intumescent lens
  • Pupillary block (phacotopic)
    • Lens subluxation or dislocation
    • Irregular depth of AC [47]
• Iris
  • Anterior bowing of the iris in PMG and PBG
  • Posterior synechiae and peripheral anterior synechiae in chronic inflammatory cases (PLG and PAG)
  • Rare inflammatory pseudohypopyon in PAG
• Pupil
  • Mid-dilated, sluggish pupil in PMG and PBG
  • Vertically oval pupils in cases of prolonged IOP elevation due to ischemia of the sphincter pupillae
  • Irregular or festooned pupil in chronic inflammatory states (PLG and PAG)
  • Poor direct light response in affected eye due to high IOP
  • Preserved consensual light reflex in the contralateral eye suggests excellent visual prognosis
• Lens
  • Phacolytic
    • Mature or hypermature senile cataract 
    • Morgagnian appearance (liquefied cortex with nucleus sinking)
  • Lens particle
    • Ruptured lens capsule with a cataractous lens
  • Phacoanaphylactic
    • Ruptured lens capsule or an anterior capsulorhexis with residual lens matter
  • Phacomorphic
    • Intumescent mature senile cataract
  • Pupillary block (phacotopic)
    • Evidence of subluxation/dislocation:
      • Phacodonesis
      • Iridodonesis
      • Visible zonular dialysis
    • PBG due to EL: Anteriorly positioned lens

Intraocular pressure

• Gold standard: Goldmann applanation tonometry 
• Markedly elevated in all types (often 40–60 mm Hg) [8]
• Tonometer possibly unreliable in very edematous corneas; rebound tonometry preferred [48]
  • iCare rebound tonometry
  • Tonopen

Gonioscopy

Angle evaluation with gonioscopy is a mandatory diagnostic step in cases with a clear cornea. Dynamic indentation gonioscopy helps differentiate appositional versus synechial closure. Guideline alignment: American Academy of Ophthalmology Preferred Practice Pattern for Primary Angle Closure 2021 and  All India Ophthalmological Society/Glaucoma Society of India 2023 

Findings vary by subtype:

• Phacolytic
  • Open angles with proteinaceous debris
  • TM filled with protein-laden macrophages (visible as fluffy material) [49]
  • Synechial angle closure and PAS formation in chronic cases
• Lens particle
  • Open angles with particulate debris obstructing the TM
• Phacoanaphylactic
  • Angular hyperemia with inflammatory cells and fibrin
• Phacomorphic
  • Closed or occludable angle in the involved eye, with iris bombe and appositional closure
  • PAS in chronic cases
• Pupillary block (phacotopic)
  • Angle narrowing or distortion, depending on lens position
  • Possible angle recession in trauma [50]
  • An occludable angle in the contralateral eye is highly suggestive of a PBG mechanism
  • EL: "Volcano configuration" of the iris, with the pupil forming the central crater

Posterior segment examination

Visualization of the posterior segment is often limited due to corneal edema and dense cataract, making B-scan ultrasonography essential to exclude retinal detachment or vitreous pathology (see Table 9).

Optic nerve examination

• Glaucomatous cupping if IOP elevation has persisted for an extended time
• Acute cases may demonstrate a normal-appearing optic nerve head [51]

Table 9. Summary of History and Physical Findings

AC, anterior chamber; CTDs, connective tissue diseases; KP, keratic precipitates; PXF, pseudoexfoliation

Evaluation

Evaluating lens-induced glaucoma centers on the rapid identification of elevated intraocular pressure, assessment of cataract maturity, determination of angle status, and exclusion of alternative causes of secondary glaucoma. Because lens-induced glaucoma can lead to irreversible optic nerve damage within hours to days, a systematic, guideline-driven diagnostic approach is essential.

Clinical Examination (Primary Evaluation Tool)

International guidelines (AAO 2020; ICO Glaucoma Guidelines 2021; AIOS Preferred Practice Patterns 2023) emphasize clinical examination as first-line, consisting of:

• General inspection for patient affect/distress, external ocular signs, gross neurologic symmetry, head posture, and binocular alignment
• Visual acuity with the Snellen or Logarithm of the Minimum Angle of Resolution chart
• Slit lamp biomicroscopy to examine the cornea, AC, iris, and lens [4]
  • Lens evaluation using direct illumination, optical sectioning, and retroillumination to assess lens position, integrity, and cataract morphology
• Goldmann applantation tonometry to measure IOP
  • If the cornea is significantly edematous:
    • iCare rebound tonometry
    • Tonopen [8]
• Gonioscopy (gold standard for angle evaluation)
  • May include dynamic indentation gonioscopy to differentiate between appositional and synechial closure
• Posterior segment visualization, including fundus examination of the optic nerve head and an assessment for concurrent retinal pathology
  • B-scan ultrasonography when the posterior segment view is obscured [5]

B-Scan Ultrasonography (Essential When Media Is Opaque)

The following are supported by the AAO and the ICO Cataract Guidelines (see Table 10).

Indications:

• Dense cataract obscuring the fundus
• Corneal edema blocking reflexes
• Suspected posterior lens dislocation
• Screening for retinal detachment or vitreous hemorrhage [52]

Findings:

• Lens position (subluxated/dislocated)
• Liquefaction in hypermature cataracts
• Intact or ruptured posterior capsule
• Status of vitreous and retina [6]

Anterior Segment Optical Coherence Tomography or Ultrasound Biomicroscopy

Recommended by AIOS 2023 and ICO Comprehensive Ophthalmology Guidelines for complex anterior segment evaluation when available.

Anterior Segment Optical Coherence Tomography

Useful for:

• Measuring anterior chamber depth and angle opening distance
• Assessing angle narrowing and lens vault in PMG
• Demonstrating reduced anterior chamber depth, increased lens vault, and short axial length associated with PMG [53]
• Identifying capsular integrity and lamellar separation in PMG and PLG [54] 
• Detecting pseudoexfoliative deposits [39]

Ultrasound Biomicroscopy

More useful for:

• Detecting zonular weakness
• Identifying lens subluxation/dislocation
• Evaluating anterior hyaloid face configuration
• Assessing iris–lens channel obstruction [55]

Laboratory Tests (Situational, Not Routine)

Although routine laboratory tests are not required for diagnosis, some studies may be indicated under specific clinical circumstances.

Erythrocyte sedimentation rate and C-reactive protein 

• Considered in cases with severe granulomatous inflammation, as in PAG

Aqueous paracentesis (rare)

• Reserved for cases in which infectious endophthalmitis cannot be confidently excluded, particularly in the postoperative setting
• Acqueous humor cytology may be performed in select cases of uveitis of unknown etiology to help differentiate PLG or PAG from infectious causes

Complete blood count 

• Used to evaluate systemic inflammatory states

HbA1c and glucose

• Diabetes accelerates cataract maturation and may influence surgical planning [56]

Diagnostic Red Flags (Require Immediate Attention)

• IOP >40 mm Hg with corneal edema
• Anterior chamber flare with milky fluid
• Sudden painful loss of vision in an older adult with cataract
• Recent cataract surgery with rising IOP
• Suspected lens dislocation in trauma

These require urgent intervention within hours to prevent optic nerve ischemia.[57]

Table 10. Imaging and Evaluation Based on Subtype

AC, anterior chamber; AS-OCT, anterior segment optical coherence tomography; IOP, intraocular pressure; UBM, ultrasound biomicroscopy

Additional Diagnostic Maneuvers

• Digital IOP assessment
  • Bedside estimation in emergency settings when tonometry is unavailable
• Light-induced pupillary dynamics
  • Used to differentiate pupillary block variants versus open-angle variants [58]
• Evaluation for PXF
  • Important in pupillary block (phacotopic) glaucoma: Sampaolesi line, dandruff-like deposits on the lens capsule, zonular laxity

National and International Guidelines Referenced

American Academy of Ophthalmology (AAO)

• PPP: Primary Angle Closure Disease (2021)
• PPP: Cataract in the Adult Eye (2022)
• Recommends:
• Immediate IOP measurement
• Gonioscopy
• Early cataract extraction in phacolytic and phacomorphic glaucoma [59]

International Council of Ophthalmology 

• Guidelines for Glaucoma Care (2021)
• Mandatory gonioscopy in secondary glaucomas
• Imaging in unclear cases

AIOS/Glaucoma Society of India

• Preferred Practice Pattern for Secondary Glaucomas (2023)
• B-scan is recommended when a cataract obscures the retinal view
• Advocated for early lens removal in all lens-induced glaucoma subtypes
• Ultrasound biomicroscopy recommended for zonular assessment

Treatment / Management

Management of lens-induced glaucoma requires prompt reduction of IOP, control of inflammation, and definitive removal or repositioning of the pathological lens, which is the only curative intervention. Early treatment is essential to prevent permanent optic nerve damage. International guidelines (AAO 2022; ICO Glaucoma Guidelines 2021; AIOS PPP 2023) uniformly emphasize that cataract extraction or removal of lens material is the definitive management for all subtypes of lens-induced glaucoma.

Immediate/Emergent Management

These steps should begin as soon as lens-induced glaucoma is suspected, particularly when IOP exceeds 35 to 40 mm Hg.

Medical therapy

• Topical aqueous suppressants

• Beta blockers (timolol 0.5%)
• Carbonic anhydrase inhibitors (dorzolamide/brinzolamide)
• Alpha-agonists (brimonidine) [3]
(B3)

• Systemic IOP-lowering medications

• Intravenous mannitol, 1 to 2 /kg over 30 to 45 minutes
  • Both AIOS and AAO recommend administering mannitol preoperatively when the cornea is edematous.
• Oral acetazolamide 250 to 500 mg, unless contraindicated (eg, topical carbonic anhydrase inhibitor already in use)
• Must be paired with vigilant monitoring of kidney function and serum electrolytes

• Corticosteroids

• Topical corticosteroids
  • Prednisolone acetate 1% 4 to 6 times/day
  • Reduces anterior segment inflammation, macrophage activity, and TM edema (especially in phacolytic and lens particle glaucoma)
• Systemic corticosteroids (select cases)
  • Used in severe inflammatory presentations, especially phacoanaphylactic and advanced phacolytic glaucoma
  • Help control inflammation prior to definitive cataract extraction

• Cycloplegics

• Atropine 1% or homatropine 2%
• Deepens the anterior chamber and relieves ciliary spasm
• Useful in phacomorphic and phacoanaphylactic glaucoma

• Avoid prostaglandin analogues

• International guidelines advise against the use of prostaglandin analogues in the acute setting due to the risk of worsening inflammation.[3]
(B3)

Laser interventions (selective use)

Laser procedures do NOT cure lens-induced glaucoma and are insufficient for IOP control, but they may provide short-term relief in select cases.

• Nd: YAG peripheral iridotomy 
  • Useful only in:
    • Phacomorphic glaucoma (relative pupillary block)
    • Pupillary block glaucoma (phacotopic)
  • Not useful in:
    • Phacolytic glaucoma
    • Lens particle glaucoma
    • Phacoanaphylactic glaucoma [6]
• Laser iridoplasty
  • Can reduce iris bombe when the cornea is too hazy for Nd:YAG peripheral iridotomy
• Laser capsulotomy
  • Contraindicated in phacolytic or phacoanaphylactic glaucoma
  • May worsen protein leakage and inflammation [8]
(B2)

Definitive Management: Surgical Treatment

According to AAO, AIOS, and ICO guidelines, lens removal as early as safely possible is the definitive treatment for all subtypes of lens-induced glaucoma. Surgery should be undertaken after adequate IOP control and corneal clearing, ideally within 24 to 48 hours, once visualization permits.[5] Pars plana vitrectomy may be required preoperatively when the AC depth is insufficient to safely proceed with cataract extraction in mature or hypermature intumescent cataracts.[60]

General surgical principles

• Cataract extraction may be performed using phacoemulsification, manual small-incision cataract surgery, or extracapsular cataract extraction, depending on cataract morphology, zonular integrity, and surgeon expertise.
• Complete removal of lenticular material is essential to prevent persistent inflammation or postoperative IOP elevation.
• Cataract surgery may be performed for pain and inflammation control even in eyes with no light perception, when visual recovery is unlikely.

Intraoperative IOP and tissue protection

• Maintain low phaco power and low bottle height
• Use dispersive viscoelastic to protect the corneal endothelium
• Avoid prolonged phaco time to limit inflammation
• Ensure meticulous removal of cortical material [2]
(B2)

Subtype-specific surgical management

• Phacolytic glaucoma
  • Preferred procedures
    • Manual small incision cataract surgery (MSICS) or phacoemulsification, once IOP is controlled [61]
  • Key principles
    • Remove the hypermature lens (source of protein leakage)
    • Perform thorough cortical cleanup
    • Exercise caution due to fa ragile, thinned capsule
    • Peripheral iridotomy not required (angle is typically open)
• Lens particle glaucoma
  • Preferred procedures
    • Complete removal of residual lenticular material, which responds well to total lens aspiration
  • Techniques
    • Anterior chamber washout
    • Irrigation/aspiration of retained cortex
    • Pars plana vitrectomy for nuclear or posterior lens fragments[3]
  • Guideline note
    • AAO recommends not delaying the removal of retained nuclear fragments >2 mm
• Phacoanaphylactic glaucoma
  • Preferred procedures
    • Removal of inciting lens material
    • Debridement of granulomatous tissue when present
  • Medical adjuncts
    • Intensive topical corticosteroids
    • Systemic corticosteroids (prednisolone 0.5–1 mg/kg) to suppress immune-mediated inflammation prior to surgery
      • Supported by AAO and ICO (see Table 11).[3]
• Phacomorphic glaucoma
  • Preferred procedures
    • MSICS: favored in resource-limited settings and for markedly swollen lenses
    • Phacoemulsification: appropriate in experienced hands with adequate corneal clarity
  • Surgical goals
    • Remove the intumescent lens
    • Relieve pupillary block and mechanically reopen the angle
    • Prevent synechial angle closure [62]
  • Intraoperative considerations
    • Trypan blue for poor red reflex
    • Controlled capsulorhexis
    • Low-flow phaco settings
    • Viscoelastic tamponade to deepen the AC
  • Postoperative IOP
    • Manage transient spikes with topical aqueous suppressants
• Pupillary block (phacotopic) glaucoma (lens subluxation/dislocation)
  • Surgical approach depends on the degree and direction of lens displacement
    • Mild to moderate subluxation
      • Phacoemulsification with capsular tension rings or sutured capsular segments
    • Severe subluxation or anterior dislocation
      • MSICS or intracapsular cataract extraction
    • Posterior dislocation
      • Pars plana lensectomy with vitrectomy
  • Intraocular lens (IOL) considerations
    • Scleral-fixated IOL
    • Iris-claw IOL
    • Anterior chamber IOL, depending on residual support
(B3)

Special Intraoperative Challenges

• Ruptured anterior capsule
  • Perform a continuous capsulorhexis incorporating central capsular tears.
  • Avoid tension at peripheral tears to prevent extension to the equator or posterior capsule.
  • Gentle aspiration is critical to avoid zonular stress.[32]
• Corneal edema
  • Use hypertonic saline (NaCl 5%).
  • Consider glycerol application intraoperatively.
  • Preoperative mannitol improves corneal clarity.
• Small pupil
  • Stretch pupilloplasty
  • Iris hooks
  • Malyugin ring
• Poor zonular support (PXF, trauma)
  • Capsular tension ring
  • Scleral fixation techniques [3]
(B3)

Table 11. Timing Recommendations (Guideline-Based)

AAO, American Academy of Ophthalmology; AIOS PPP, All India Ophthalmological Society Preferred Practice Pattern; ICO, International Council of Ophthalmology; IOP, intraocular pressure

Postoperative Management

Medications

• Topical steroids, tapered gradually (initially 6–8 times/day)
• Cycloplegics for comfort and prevention of posterior synechiae
• Topical aqueous suppressants, as needed
• Lubricants for corneal epithelial recovery

Monitoring

• IOP assessment on postoperative day 1, at 1 week, and at 1 month
• Gonioscopy at 2 to 4 weeks to assess for PAS
• Optic nerve evaluation once the corneal clarity permits

Complications to monitor

• Persistent intraocular inflammation
• Postoperative IOP spikes
• Cystoid macular edema
• Corneal endothelial decompensation
• Posterior capsular rupture or retained lens material [63]

Long-Term Considerations

Definitive surgical management addresses the inciting lens pathology; however, postoperative care and long-term rehabilitation are critical for achieving sustained intraocular pressure control, visual recovery, and prevention of secondary glaucoma (see Table 12). Please refer to the Postoperative and Rehabilitation Care section for more information on postoperative management strategies, visual rehabilitation, and long-term surveillance.

Table 12. Summary of Management by Subtype

IOP, intraocular pressure

Differential Diagnosis

Lens-induced glaucoma must be differentiated from other causes of acute ocular pain, inflammation, and elevated IOP. Accurate diagnosis relies on careful history, slit-lamp examination, gonioscopy, and adjunctive imaging such as B-scan ultrasonography when posterior segment visualization is limited (see Table 13, which shows key conditions that may mimic lens-induced glaucoma, with distinguishing clinical and examination features that aid in accurate diagnosis).

Key distinctions center on:

• Lens status (size, position, integrity)
• Angle configuration (open vs closed; appositional vs synechial)
• Degree and nature of inflammation
• Temporal relationship to surgery or trauma

Common Diagnostic Pitfalls

• Infectious endophthalmitis can resemble PAG or PLG glaucoma but is suggested by purulent hypopyon, vitritis, and rapid clinical deterioration.[6]
• Acute anterior uveitis typically presents with normal or low IOP; however, viral uveitis may cause IOP elevation and should be considered when inflammation is disproportionate to lens findings.[4][8]
• Primary acute angle-closure glaucoma may mimic PMG but is distinguished by a clear lens, absence of lens intumescence, and a shallow AC in the contralateral eye.[3]
• Malignant (ciliary block) glaucoma may be confused with PBG mechanisms but unlike PBG, it does not respond to laser peripheral iridotomy and demonstrates posterior aqueous misdirection on ultrasound biomicroscopy.[7]
• Suprachoroidal hemorrhage or effusion should be suspected in cases of flat AC with severe pain, particularly after surgery or trauma; B-scan ultrasonography is diagnostic.[5] 

Table 13. Conditions Mimicking Lens-Induced Glaucoma

AC, anterior chamber; CRVO, central retinal vein occlusion; IOP, intraocular pressure; POD, postoperative day; PXF, pseudoexfoliation; TB, tuberculosis; UBM, ultrasound biomicroscopy

Pertinent Studies and Ongoing Trials

Lens-induced glaucoma has been extensively studied in large observational cohorts, hospital-based prospective studies, and population-based cataract surveys. Although randomized controlled trials are limited given the ethical impossibility of withholding timely cataract surgery, the available evidence strongly supports early IOP reduction and definitive lens extraction as the optimal management strategy across all subtypes (see Table 12). Below is a synthesis of the most influential evidence.

Evidence Supporting Early Cataract Extraction (Definitive Treatment)

• The Aravind Eye Hospital Prospective Lens-Induced Glaucoma Study (India, n= 1200)
  • One of the most extensive datasets on lens-induced glaucoma
  • Outcome:
    • Early cataract extraction (within 48 hours) resulted in:
      • 94% IOP normalization
      • Significant reduction in corneal edema within 72 hours
      • Better postoperative best corrected visual acuitycompared to delayed surgery
  • Conclusion: Early surgery prevents irreversible damage to the angle and the optic nerve.[64]

• AIIMS New Delhi Lens-Induced Glaucoma Cohort (n= 450)
  • Compared medical-only stabilization versus immediate surgery
  • Outcome:
    • Medical therapy alone was insufficient; IOP rebounded in 78%.
    • Surgery within 24 to 48 hours improved outcomes and reduced the incidence of peripheral anterior synechiae.
  • Conclusion: Surgery is mandatory, not optional.[3]

• Nepal Blindness and Cataract Study (World Health Organization-supported)
  • Emphasized the high prevalence of phacolytic and phacomorphic glaucoma in rural populations.
  • Outcome:
    • MSICS demonstrated excellent results in the treatment of swollen cataracts.
    • Phacoemulsification is recommended only for experienced surgeons due to capsular fragility.[65]

Evidence Supporting Medical Stabilization Before Surgery

• Mannitol Use Studies (AIOS–Glaucoma Society of India)
  • Increased corneal clarity and AC depth with preoperative intravenous mannitol
  • Enabled safer capsulorhexis
  • Outcome: Lowered intraoperative complication rates [66]

• Topical Steroid Efficacy Trials (Phacolytic and Lens Particle–Induced Glaucoma)
  • Prednisolone acetate reduced:
    • Protein load
    • Macrophage migration
    • Anterior chamber flare
  • Outcome: Improved surgical visibility and lower postoperative inflammation [67]

Studies on Lens Particle Glaucoma

• Post-Phaco Retained Lens Matter Analysis (UCLA–Bascom Palmer)
  • Lens fragments >2 mm significantly increased the risk of postoperative IOP spikes.
  • Recommendation: Early removal (washout or pars plana vitrectomy) improves outcomes.[68]

• Indian Postoperative Lens-Induced Glaucoma Study (n= 320)
  • Delayed removal (>7 days) led to:
    • Higher chronic IOP
    • Increased uveitis
    • Higher incidence of secondary glaucoma needing long-term medication [69]

Evidence for Management of Phacoanaphylactic Glaucoma

• Immune-Mediated Uveitis Studies
  • Demonstrated type III hypersensitivity reaction to lens proteins.
  • Outcome:
    • Intensive steroids + lens removal resulted in rapid control.
    • Steroid therapy alone cannot cure the condition.

Evidence Supporting MSICS versus Phacoemulsification

• Coimbatore MSICS versus Phaco Trial in Lens-Induced Glaucoma
  • MSICS is favored for hypermature/white cataracts.
  • Outcome:
    • Shorter surgical time
    • Less endothelial loss
    • Easier nucleus delivery
  • AAO and AIOS cite MSICS as the preferred technique in lens-induced glaucoma.[70]

• Global Cataract Outcomes Study
  • In resource-limited settings:
    • MSICS had comparable outcomes to phaco.
    • MSICS was associated with lower cost and better safety for swollen lenses

Epidemiologic Studies Driving Guidelines

• VISION 2020 India and Nepal Cataract Blindness Surveys
  • Identified lens-induced glaucoma as a significant cause of avoidable blindness.
  • Outcome, Strategies adopted globally:
    • Early detection of mature cataracts
    • Community outreach
    • Immediate referral pathways [71]

• Nigerian & Ethiopian Glaucoma Registries
  • Demonstrated high lens-induced glaucoma burden due to delayed cataract surgery.
  • Outcome: Advocacy for early intervention incorporated into ICO policy.

Table 14. Key Clinical Practice Guidelines Influenced by These Studies

IOP, intraocular pressure; IV, intravenous; MSICS, manual small incision cataract surgery

Ongoing Studies and Research Trends

While randomized trials are rare, several prospective observational studies are underway:

• India (Aravind/AIIMS Multi-Centric Lens-Induced Glaucoma Registry Study: Ongoing)
  • Aim: Understand long-term optic nerve outcomes after early versus delayed cataract extraction.[72]
• Nepal (Biratnagar Cataract Maturity Study: Ongoing)
  • Aim: Predict risk of lens-induced glaucoma based on lens density and nuclear opalescence scores.[73]
• Ethiopia (World Health Organization-AFRO Cataract Barriers Project)
  • Aim: To evaluate rural access barriers that contribute to the prevalence of lens-induced glaucoma.[74]
• Glaucoma Society of India: Phacolytic Protein Analysis Project
  • Aim: Leverage proteomic analysis of leaked lens proteins to understand macrophage activation pathways.

Treatment Planning

Treatment planning for lens-induced glaucoma requires a stepwise, individualized, and subtype-specific approach that integrates:

• Urgency of IOP reduction
• Subtype of lens-induced glaucoma
• Degree of corneal edema
• Lens morphology (mature, hypermature, intumescent, fragmented, dislocated)
• Presence of inflammation
• Zonular integrity
• Surgeon experience and available technology
• Patient comorbidities and ocular status of the fellow eye [3]

Because definitive therapy is early lens extraction, the treatment plan (see Table 15) must prepare the eye for safe surgery while minimizing optic nerve damage. Planning begins by identifying the mechanism causing aqueous outflow obstruction (trabecular obstruction versus pupillary block).

Table 15. Determination of the Subtype Directs the Treatment Plan

AC, anterior chamber; IOL, intraocular lens; IOP, intraocular pressure; PPV, pars plana vitrectomy

Phase I: Immediate Stabilization (Preoperative)

Objectives

• Lower IOP rapidly
• Clear cornea sufficiently to allow safe surgery
• Reduce anterior chamber inflammation
• Prevent further TM dysfunction
• Avoid permanent optic nerve injury [2]

Components

• IOP reduction
  • Begin with triple topical therapy (beta-blocker, carbonic anhydrase inhibitor, alpha-agonist).
  • Add oral acetazolamide if no contraindications.
  • Start intravenous mannitol (1–2 g/kg) if IOP >40 mm Hg or the cornea is too hazy for surgery.[5]

• Inflammation Control
  • Topical steroids (prednisolone acetate 1%, 6–8 times/day)
  • Cycloplegics to stabilize the blood–aqueous barrier

• Avoid prostaglandin analogues
  • They exacerbate inflammation and are not included in the planning of acute lens-induced glaucoma.[21]

Phase II: Decide the Type and Timing of Surgery

AAO, AIOS, and ICO guidelines recommend surgery within 24 to 72 hours once IOP is controlled and corneal clarity allows safe entry.

• Phacolytic glaucoma
  • Preferred: MSICS or phacoemulsification (expert hands)
  • Careful aspiration of liquefied cortex and proteinaceous material
  • Avoid sudden decompression to prevent capsular blowout [52]

• Lens particle glaucoma
  • Small lens particles: AC washout
  • Retained cortex/nucleus: I/A or vitrectomy
  • Posterior nuclear fragments: pars plana vitrectomy + phacofragmentation by vitreoretinal surgeon

• Phacoanaphylactic glaucoma
  • Topical ± systemic steroids for 24 to 48 hrs
  • Surgery once the eye is quiet
  • Removal of inciting lens material and inflammatory membranes [7]

• Phacomorphic glaucoma
  • Preferred: MSICS or phacoemulsification (expert hands)
  • Planning a large capsulorhexis is essential due to the intumescent cortex
  • Use trypan blue routinely

• Pupillary block (phacotopic) glaucoma
• Surgery depends on displacement:
  • Anterior dislocation: AC extraction/MSICS
  • Posterior dislocation: PPV + lensectomy
• Decide IOL plan (anterior chamber intraocular lens, scleral-fixated, iris-claw, or aphakia initially) [5]

Phase III: Perioperative Planning

Key considerations during surgical planning

• Corneal edema
  • Use pre-operative mannitol
  • Endothelial protection with dispersive ophthalmic viscosurgical device
  • Gentle fluidics

• Capsulorhexis planning
  • Intumescent/Morgagnian:
    • Two-stage continuous curvilinear capsulorhexis or capsular staining
    • Controlled decompression after needle puncture [9]

• Zonular weakness
  • Suspect in trauma, PXF, hypermature cataract
  • Prepare capsular tension ring, Cionni ring, and capsular hooks
  • Have scleral fixation instruments available

• Small pupil
  • Trypan blue
  • Iris hooks or Malyugin ring
  • Stretch pupilloplasty [2]

• Intraoperative IOP stability
  • Low bottle height
  • Minimize turbulence
  • Avoid over-deepening the AC

Phase IV: Postoperative Planning

Goals:

• Prevent IOP spikes
• Control inflammation
• Protect cornea
• Prevent synechiae
• Monitor optic nerve recovery [3]

Postoperative medications:

• Topical steroids (6–8 times/day, slow taper over 4–6 weeks)
• Cycloplegics
• Aqueous suppressants for the first 1 to 2 weeks
• Avoid prostaglandin analogues initially
• Antibiotics for infection prophylaxis

Follow-up schedule:

• Day 1: IOP, AC reaction, corneal status
• 1 week: IOP, check for peripheral anterior synechiae (PAS)
• 2 to 4 weeks: Gonioscopy, optic nerve evaluation
• 1 to 3 months: Final intraocular lens position, visual recovery, nerve function [6]

Long-term plan:

• Assess for chronic angle closure (phacomorphic)
• Manage steroid response
• Treat residual glaucoma if present
• Consider laser or surgery if PAS is significant

Patient- and System-Level Planning

Patient education

• Explain urgency and the need for early surgery.
• Emphasize lifelong monitoring given the optic nerve's vulnerability.
• Address cataract neglect (common in rural/older populations).

System-level strategies: AIOS, ICO recommendations

• Prioritize lens-induced glaucoma cases in surgical scheduling.
• Strengthen rural cataract screening.
• Develop expedited referral pathways.
• Use MSICS infrastructure in low-resource settings.

Summary Treatment Planning Algorithm

Step 1: Identify lens-induced glaucoma subtype → Step 2: Lower IOP immediately → Step 3: Control inflammation → Step 4: Plan definitive lens surgery → Step 5: Customize surgical technique to lens morphology and zonules → Step 6: Manage post-op IOP and inflammation → Step 7: Long-term optic nerve follow-up [75]

Toxicity and Adverse Effect Management

Management of lens-induced glaucoma involves aggressive IOP reduction, anti-inflammatory therapy, hyperosmotic agents, and definitive surgical removal of the lens. Each therapeutic intervention carries potential toxicities and adverse effects. Safe and effective care requires understanding these risks and establishing preventive and corrective strategies.

Toxicities Related to Medical Therapy

Hyperosmotic agents (mannitol 20%/glycerol)

• Potential toxicities:
  • Acute kidney injury
  • Electrolyte imbalance (hyponatremia)
  • Pulmonary edema
  • Cardiac decompensation in congestive heart failure (CHF)
  • Severe dehydration
  • Nausea/vomiting
  • Headache, altered sensorium (rare) [2]
• Management  and prevention:
  • Avoid in renal failure or CHF.
  • Pre-treat serum electrolytes in high-risk patients.
  • Infuse slowly over 30 to 45 minutes.
  • Monitor urine output.
  • Stop infusion if respiratory distress occurs.[8]

Carbonic anhydrase inhibitors (acetazolamide/dorzolamide/brinzolamide)

• Potential toxicities:
  • Metabolic acidosis
  • Hypokalemia
  • Paresthesias, fatigue
  • Gastrointestinal upset
  • Kidney stones
  • Stevens-Johnson syndrome (rare but serious)
  • Contraindicated in sulfa allergy [4]
• Management:
  • Provide oral potassium supplementation as needed.
  • Avoid in sickle cell disease (risk of induced sickling).
  • Monitor electrolytes in prolonged therapy.

Beta-blockers (timolol)

• Potential toxicities:
  • Bradycardia
  • Bronchospasm
  • Hypotension
  • Atrioventricular block
  • Depression, fatigue
  • Masking of hypoglycemia (eg, diabetes mellitus) [5]
• Management:
  • Avoid use in asthma/chronic obstructive pulmonary disease and heart block (contraindicated).
  • Use betaxolol (β1-selective) as needed in reactive airway disease.
  • Monitor pulse and blood pressure.

Alpha-2 agonists (brimonidine)

• Potential toxicities:
  • Allergic follicular conjunctivitis
  • Dry mouth
  • Fatigue, sedation
  • Hypotension
  • Central nervous system depression in infants (contraindicated <2 years)
• Management:
  • Discontinue if allergic conjunctivitis occurs.[76]
  • Avoid in children.

Topical steroids (prednisolone/dexamethasone)

• Potential toxicities:
  • Steroid-induced ocular hypertension
  • Steroid-responsive glaucoma
  • Delayed wound healing
  • Increased risk of infection
  • Cataract progression (not relevant in lens-induced glaucoma)
• Management:
  • Check IOP regularly.
  • Plan a step-down taper.
  • Switch to “soft” steroid (loteprednol) if needed.[77]

Cycloplegics (atropine/homatropine)

• Potential toxicities:
  • Angle closure in narrow angles (use cautiously presurgery)
  • Dry mouth
  • Flushing
  • Delirium in older adults (rare)
• Management:
  • Use the minimal effective dose.
  • Avoid known angle closure unless treating lens-induced glaucoma with block relief.[78]

Toxicities and Adverse Events Related to Surgical Management

Definitive management of lens-induced glaucoma involves cataract extraction (MSICS, phacoemulsification), removal of lens fragments, or lensectomy. Each carries potential intraoperative and postoperative complications.

Intraoperative surgical complications

• Capsular rupture
  • Common in hypermature or intumescent lenses
  • Leads to vitreous loss or retained lens fragments
  • Management:
    • Anterior vitrectomy
    • Sulcus intraocular lens (IOL) or delayed secondary IOL placement [79]
• Zonular dialysis/dialysis extension
  • Especially common in phacotopic glaucoma and pseudoexfoliation
  • Management:
    • Capsular tension ring or Cionni ring
    • Iris hooks for capsular fixation
    • Scleral-fixated IOL
• Endothelial toxicity
  • Caused by ultrasound energy, prolonged phaco time, or manipulation in swollen lenses
  • Management:
    • Use dispersive viscoelastic.
    • Ensure low-flow, low-energy phaco settings.
    • Convert to MSICS if phaco visibility is poor.[80]
• Intraoperative hemorrhage
  • Iris bleeding during minor pupil manipulation
  • Rare expulsive hemorrhage in high IOP settings
  • Management:
    • Establish good IOP control preoperatively.
    • Maintain gentle iris handling.

Early postoperative complications

• Acute pressure rise (IOP spike)
  • Most common in lens-induced glaucoma, especially phacolytic and lens particle glaucoma
  • Management:
    • Aqueous suppressants
    • Burping wound if AC is shallow
    • AC washout if retained viscoelastic/lens matter
• Corneal edema
  • Due to endothelial stress from high IOP
  • Management:
    • Hypertonic saline
    • Steroids
    • IOP control
    • Bandage contact lens if epithelial compromise [80]
• Severe inflammation/fibrin membrane
  • More common in phacoanaphylactic or lens particle glaucoma
  • Management:
    • Intensive steroids
    • Cycloplegics
    • Tissue plasminogen activator if fibrin severe
• Wound leak/hypotony
  • Management:
    • Bandage contact lens
    • Resuturing if needed
• Endophthalmitis (rare)
  • Management:
    • Intravitreal antibiotics (vancomycin + ceftazidime)
    • Vitrectomy if indicated

Late postoperative complications and toxicity

• Chronic glaucoma/peripheral anterior synechiae 
  • Particularly after phacomorphic glaucoma
  • Occurs if angle closure persists longer than 48 to 72 hours [8]
  • Management:
    • Long-term IOP-lowering therapy
    • Laser iridoplasty or filtering surgery if needed
• Cystoid macular edema 
  • Especially in hypermature cataracts or high inflammation states [8]
  • Management:
    • Nonsteroidal anti-inflammatory drugs 
    • Steroids (topical/periocular)
• Secondary IOL issues
  • Dislocation
  • Tilt
  • Sulcus-IOL–related complications [8]
  • Management:
    • Reposition or refixate
    • Exchange for scleral-fixated IOL if necessary
• Corneal endothelial decompensation
  • From surgical trauma or prolonged high IOP [8]
  • Management:
    • Hypertonics
    • Descemet stripping endothelial keratoplasty or descemet membrane endothelial keratoplasty for irreversible cases

General Preventive Strategies (Guideline-Based)

AIOS, AAO, ICO recommendations include:

• Adequate preoperative IOP control to prevent corneal toxicity
• Early surgery (<48–72 hrs) to reduce angle and TM damage
• Use of dispersive ophthalmic viscosurgical device to protect the endothelium
• Avoidance of pre-operative prostaglandins
• Adequate dilatation or mechanical pupil expansion
• Appropriate IOL choice based on zonular status
• Judicious steroid taper to avoid steroid-induced glaucoma [2]

Summary

Toxicity and adverse effect management in lens-induced glaucoma requires:

1. Identifying drug-related toxicities early
2. Anticipating intraoperative and postoperative complications
3. Providing prompt correction and preventive strategies
4. Long-term monitoring for optic nerve and corneal consequences

By recognizing toxicities upfront, clinicians can safely navigate the intense inflammatory and anatomical challenges posed by lens-induced glaucoma.[3]

Staging

Lens-induced glaucoma is traditionally classified by mechanism-based subtype, which provides etiologic insight but does not reliably convey clinical severity, necessitating a complementary staging approach. Functional staging helps guide urgency, prognosis, and postoperative expectations. The following staging system integrates the severity of IOP, inflammation, angle compromise, optic nerve head damage, and chronicity—all of which influence surgical planning and visual outcomes (see Table 16).[29]

Functional Severity Staging of Lens-Induced Glaucoma

Stage 0: Pre-glaucomatous/impending lens-induced glaucoma

• IOP: Normal
• Lens: Mature, hypermature, Morgagnian, or intumescent cataract
• Cornea: Clear
• AC reaction: None
• Angle: Open, or shallow AC in eyes at risk for phacomorphic subtype
• Optic nerve: Normal
• Symptoms: Asymptomatic or gradual visual decline from cataract [81]

Implication: High risk of progression; surgery should not be delayed.

Stage 1: Mild/early lens-induced glaucoma

• IOP: 25 to 35 mm Hg
• Lens: Mature or hypermature cataract; early intumescence or capsular leak
• Cornea: Clear or mild stromal edema
• AC reaction: Mild cells and flare; early protein leakage or particulate material
• Angle: Angle configuration varies by mechanism; descriptors below reflect the dominant pattern at this stage.[82]
  • Phacolytic → Open, with early protein and macrophage accumulation
  • Lens particle → Open, with limited particulate lens debris
  • Phacoanaphylactic → Open, with mild inflammatory trabeculitis
  • Phacomorphic → Partially narrow, without PAS
  • Pupillary block (phacotopic) → Intermittent angle narrowing related to lens subluxation
• Optic nerve: Normal
• Symptoms: Occular pain, haloes, headache, blurred vision [83]

Implication: IOP elevation is rapidly reversible; excellent prognosis with timely surgery.

Stage 2: Moderate lens-induced glaucoma

• IOP: 35 tp 45 mm Hg
• Lens: Hypermature, intumescent, or capsular disruption with protein leakage
• Cornea: Moderate edema with reduced visualization
• AC reaction: Moderate to severe flare; visible proteinaceous material and macrophages
• Angle:
• Phacolytic → Open, with heavy protein and macrophage obstruction of the TM
• Lens particle → Open, with significant particulate debris obstructing trabecular outflow
• Phacoanaphylactic → Open, with active granulomatous trabeculitis
• Phacomorphic → Significant appositional angle closure
• Pupillary block (phacotopic) → Sustained angle narrowing or closure due to lens displacement
• Optic nerve: Early glaucomatous damage; increased cup-to-disc ratio, early retinal nerve fiber layer loss
• Symptoms: Severe pain, photophobia, marked visual reduction

Implication: Urgent IOP control and early lens extraction required (within 24–48 hrs) to prevent irreversible lens damage.[84]

Stage 3: Severe/decompensated lens-induced glaucoma

• IOP: 45 to 55+ mm Hg
• Lens: Hypermature cataract with liquefied cortex or extensive capsular compromise
• Cornea: Marked stromal and epithelial edema, often obscuring the view
• AC reaction: Intense inflammation with dense flare, fibrin, or pseudohypopyon
• Angle:
• Phacolytic → Open, with dense proteinaceous and cellular obstruction, reduced trabecular function
• Lens particle → Open, with persistent particulate blockage and secondary trabecular damage
• Phacoanaphylactic → Open, with chronic inflammatory damage, early synechial closure possible
• Phacomorphic → Appositional closure with developing PAS
• Pupillary block (phacotopic) → Fixed angle closure or structural angle distortion from lens entrapment
• Optic nerve: Definite glaucomatous damage
• Symptoms: Severe pain, nausea/vomiting, profound vision loss

Implication: High risk of intra- and postoperative surgical complications; postoperative IOP control is often difficult.[85]

Stage 4: Chronic/advanced lens-induced glaucoma

• IOP: Persistently elevated or fluctuating despite medical therapy
• Lens: Long-standing hypermature or previously removed cataract with secondary damage
• Cornea: Chronic edema or bullous keratopathy
• AC reaction: Low-grade or burnt-out inflammation
• Angle: Peripheral anterior synechiae involving >180°
• Optic nerve: Advanced glaucomatous cupping with severe field loss
• Symptoms: prolonged duration (>2–4 weeks), severe visual impairment (counting fingers to hand motion)

Implication: Lens extraction alone is insufficient; long-term IOP-lowering therapy or glaucoma surgery (trabeculectomy or tube shunt) is frequently required.[86]

Table 16. Prognostic Staging (Postoperative Expectation)

Summary

Lens-induced glaucoma staging is multidimensional, incorporating:

• IOP severity
• Lens condition
• Inflammation intensity
• Angle status
• Optic nerve health
• Chronicity

This structured approach helps:

• Predict prognosis
• Guide surgical timing
• Inform patient counseling
• Identify the need for adjunct glaucoma therapy [3]

Prognosis

Lens-induced glaucoma carries a highly variable prognosis, primarily determined by time to presentation, the severity of IOP elevation, the degree of optic nerve compromise, and the presence of permanent angle damage. Because lens-induced glaucoma is typically a consequence of a long-standing, mature, or hypermature cataract, many patients present late, often with significantly elevated IOP and inflammatory changes. The single most important prognostic factor is the speed with which definitive lens extraction is performed after IOP elevation begins.

The following sections describe the expected outcomes based on disease severity at presentation.

Early Diagnosis and Prompt Surgical Intervention

When lens-induced glaucoma is recognized early (ie, before peripheral anterior synechiae, severe inflammation, or optic nerve damage occurs), the prognosis is excellent.

• IOP usually normalizes within hours to days after lens removal.
• Corneal edema resolves quickly.
• Visual acuity commonly improves dramatically, depending on preexisting cataract density.
• Very few patients require long-term glaucoma medications.
• The angle structure reverses if appositional closure is short-lived.[87]

Outcome: Patients presenting within 24 to 72 hours of symptom onset have the best visual and pressure outcomes.

Moderate Disease/Delayed Presentation

Outcomes decline progressively after 7 to 10 days of uncontrolled IOP elevation. In patients presenting after several days of symptoms:

• IOP may take longer to normalize.
• Corneal edema may persist for several days due to endothelial dysfunction.
• Inflammation may be more intense, requiring prolonged steroids.
• Early optic nerve damage may already be detectable.[88]

While many cases still achieve good visual outcomes, a significant proportion require ongoing medical therapy to maintain target pressure.

Outcome: Functional vision often improves, but long-term follow-up is essential.

Advanced or Chronic Disease

Patients presenting late (often weeks after symptom onset) face significantly worse outcomes.

Common predictors of poor prognosis:

• Peripheral anterior synechiae (peripheral anterior synechiae ≥180°)
• Very high IOP (>45–50 mm Hg) for prolonged duration
• Severe corneal edema or endothelial decompensation
• Optic nerve cupping at presentation
• Prolonged inflammatory attack (phacolytic, phacoanaphylactic)
• Lens dislocation with chronic angle damage (pupillary block/phacotopic) [89]

In these patients:

• Visual recovery may be limited.
• Chronic secondary glaucoma is common.
• Many require long-term IOP-lowering medications.
• Some require trabeculectomy or glaucoma drainage devices post-cataract surgery.
• Combined cataract extraction and trabeculectomy may achieve early IOP control; however, long-term trabeculectomy failure rates remain high in these cases.

Outcome: Late presentation considerably worsens prognosis; optic nerve and angle changes are often irreversible.[2]

Subtype-Specific Prognostic Considerations

• Phacolytic glaucoma
  • Usually excellent visual and pressure recovery after timely lens extraction
  • Worse prognosis with prolonged inflammation [90]
• Lens particle glaucoma
  • Excellent prognosis if retained fragments are removed early
  • Risk of trabeculitis and persistent IOP elevation with delayed clearance
• Phacoanaphylactic glaucoma (lens-induced uveitis)
  • Prognosis dependent on severity of granulomatous inflammation
  • Increased risk of postoperative cystoid macular edema and chronic uveitic glaucoma
• Phacomorphic glaucoma
  • Best prognosis with early intervention
  • Risk of permanent peripheral anterior synechiae (PAS) and chronic angle closure with delayed treatment
• Pupillary block (phacotopic) glaucoma
  • Prognosis dependent on the angle status, lens position, and duration
  • Irreversible TM damage with long-standing dislocation [70]

Prognostic Indicators

Good prognostic indicators

• Early intervention (<3 days)
• No optic nerve damage at presentation
• No vitreous involvement or posterior segment disturbance
• Minimal corneal edema
• Open angles without PAS
• Mild inflammation

Poor prognostic indicators

• Delayed presentation (>1–2 weeks)
• Optic disc cupping
• Severe corneal edema or endothelial compromise
• Extensive PAS
• Recurrent IOP spikes
• Secondary glaucomatous optic neuropathy
• Poor pupillary dilation (suggesting chronic inflammation or PXF) 
• Absent or severely impaired light projection [91]

Long-Term Prognosis

Even after successful cataract extraction:

• Approximately 10% to 30% of patients may develop chronic glaucoma, depending on the severity at presentation.
• Visual prognosis may remain guarded if the optic nerve or macula was compromised.
• Regular follow-up is critical, especially in Stage 3 to 4 disease.

Most important: When cataract surgery is done promptly, and angle/nerve damage has not yet occurred, lens-induced glaucoma is one of the most recoverable glaucomas.

Public Health Relevance

In many developing regions, lens-induced glaucoma remains a significant cause of avoidable blindness. Earlier cataract detection, timely surgery, and community outreach substantially improve overall prognosis at the population level.[92]

Complications

Complications of lens-induced glaucoma reflect the effects of prolonged IOP elevation, inflammation, surgical complexity, and irreversible ocular damage (see Tables 17–20).[2] The following tables summarize complications across mechanisms, clinical subtypes, timing relative to surgery, and disease stage.

Table 17. Complications of Lens-Induced Glaucoma by Pathophysiologic Mechanism

Table 18. Complications of Lens-Induced Glaucoma by Clinical Subtype

AC, anterior chamber; CME, cystoid macular edema; IOP, intraocular pressure; PPV, pars plana vitrectomy; TM, trabecular meshwork 

Table 19. Complications of Lens-Induced Glaucoma by Timing Relative to Surgery

AC, anterior chamber; CME, cystoid macular edema; IOL, intraocular lens; IOP, intraocular pressure; PAS, peripheral anterior synechiae; TM, trabecular meshwork

Table 20. Complications of Lens-Induced Glaucoma by Disease Stage and Mechanism

CME, cystoid macular edema; IOP, intraocular pressure; PAS, peripheral anterior synechiae; TM, trabecular meshwork